Cargando…

Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?

BACKGROUD: Coronavirus disease (COVID-19) is a new respiratory infectious disease, and there is no vaccine currently. Previous studies have found that BCG vaccination can provide extensive protection against respiratory infectious diseases. METHODS: Herein, we obtained the latest data from the World...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Wenping, Wu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tuberculosis Association of India. Published by Elsevier B.V. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641523/ https://www.ncbi.nlm.nih.gov/pubmed/34099209 http://dx.doi.org/10.1016/j.ijtb.2020.10.012

Ejemplares similares

Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
por: Aspatwar, Ashok, et al.
Publicado: (2021)

Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2021)

Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis
por: Gong, Wenping, et al.
Publicado: (2023)

Improvement of Thermal Stability of BCG Vaccine
por: Sefidi, Fatemeh Jahanbakhsh, et al.
Publicado: (2017)

Natural unblinding of BCG vaccination trials
por: Szigeti, Reka, et al.
Publicado: (2021)

Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model
por: Rahali, Nadia, et al.
Publicado: (2022)

Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2020)

Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
por: Singh, Samer, et al.
Publicado: (2022)

The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues
por: Gong, Wenping, et al.
Publicado: (2022)

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy
por: Gong, Wenping, et al.
Publicado: (2021)

Peptide-Based Vaccines for Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2022)

Advances in Key Drug Target Identification and New Drug Development for Tuberculosis
por: Mi, Jie, et al.
Publicado: (2022)

Effectiveness of booster BCG vaccination in preventing Covid-19 infection
por: Amirlak, lradj, et al.
Publicado: (2021)

An effective weapon against biofilm consortia and small colony variants of MRSA
por: Mirani, Zulfiqar Ali, et al.
Publicado: (2020)

Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19
por: Sharma, Abhay
Publicado: (2021)

Conditionality of COVID-19 vaccine acceptance in European countries
por: Heyerdahl, Leonardo W., et al.
Publicado: (2022)

The “Out of Africa Tribe” (II): Paleolithic warriors with big canoes and protective weapons
por: Moreno, Eduardo
Publicado: (2013)

BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents
por: Gong, Wenping, et al.
Publicado: (2022)

Effectiveness of BCG vaccination to aged mice
por: Ito, Tsukasa, et al.
Publicado: (2010)

BCG Vaccine: Tuberculosis—Cancer
por: Pimm, M. V.
Publicado: (1980)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil
por: Gramacho, Wladimir G., et al.
Publicado: (2021)

Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
por: Alhinai, Zaid A., et al.
Publicado: (2021)

COVID-19 vaccine roll-out at the community level in developing countries: Lessons learnt from Cross River State, Nigeria
por: Emeka, Chisom, et al.
Publicado: (2022)

COVID-19 Severity and Neonatal BCG Vaccination among Young Population in Taiwan
por: Su, Wei-Ju, et al.
Publicado: (2021)

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
por: Tomita, Yusuke, et al.
Publicado: (2020)

From self‐defeating to other defeating: Examining the effects of leader procrastination on follower work outcomes
por: Legood, Alison, et al.
Publicado: (2018)

The Missile and the Weapon
por: Hall, A. L.
Publicado: (1900)

Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities
por: Hayman, Benoit, et al.
Publicado: (2021)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
por: Du, Jingli, et al.
Publicado: (2023)

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
Publicado: (2015)

Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country
por: Chang, Chee Tao, et al.
Publicado: (2022)

Democratic societies defeat (COVID-19) disasters by boosting shared knowledge
por: Martignon, Laura, et al.
Publicado: (2021)

Gain of function in Mycobacterium bovis BCG Moreau due to loss of a transcriptional repressor
por: Monteiro-Maia, Renata, et al.
Publicado: (2018)

BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study
por: Urashima, Mitsuyoshi, et al.
Publicado: (2020)

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
por: Ghazvini, K., et al.
Publicado: (2021)

Development of a diagnostic compatible BCG vaccine against Bovine tuberculosis
por: Chandran, Aneesh, et al.
Publicado: (2019)

Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis
por: Abay, Zhandos, et al.
Publicado: (2023)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
por: Taniguchi, Keiichi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g7uum5lvum3ktfcdit9r9q9gb1